© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 16, 1202-1203,
August 15, 2001
© 2001 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Robert D. Fry, M.D.,
was elected president of the American Society of Colon and Rectal Surgeons.
|
Fry is the chief of the Division of Colon and Rectal Surgery at Thomas Jefferson University, Philadelphia, and Marks Professor of Colon and Rectal Surgery at Jefferson Medical College.
Fry succeeds past president John M. MacKeigan, M.D., of Grand Rapids, Mich.
Several other officers were elected to the ASCRS Executive Council. Richard Billingham, M.D., clinical professor, Department of Surgery, University of Washington, Seattle, is the president-elect; Yanek S. Y. Chiu, M.D., associate clinical professor of surgery at the University of California at San Francisco, is vice president; and James W. Fleshman, M.D., chief of the Section of Colon and Rectal Surgery at Barnes-Jewish Hospital of St. Louis, and Frank G. Opelka M.D., who oversees a clinical surgical practice in New Orleans, were named members-at-large.
Smith Elected
Joseph A. Smith Jr., M.D., was elected president of the Society of Urologic Oncology at its annual meeting in Anaheim, Calif.
Smith is William L. Bray Chair in Urologic Surgery and co-director of the Genitourinary Oncology Program at Vanderbilt-Ingram Cancer Center, Nashville.
The society represents urologic surgeons, medical oncologists, radiation oncologists, and researchers with a primary focus on urologic cancer, which includes kidney, bladder, and prostate tumors.
Grants Awarded
The Leukemia & Lymphoma Society awarded $22.5 million in grants to three interdisciplinary research teams for projects aimed at accelerating the discovery of treatments for blood-related cancers through its Specialized Center of Research program.
Stephen D. Nimer, M.D., will lead a research team at Memorial Sloan-Kettering Cancer Center and Rockefeller University, both in New York, in studying how genetic lesions that disrupt the function of key regulatory nuclear proteins lead to the development and progression of leukemia.
Carl H. June, M.D., will lead research teams at the Cancer Center of the University of Pennsylvania and the Children’s Hospital of Philadelphia in focusing on a variety of patient-specific cellular therapies.
Jerry M. Adams, Ph.D., and his team at the Walter and Eliza Hall Institute in Melbourne, Australia, will develop new medicines for lymphoma.
The SCORs will each receive $1.5 million per year for 5 years, totaling $7.5 million, for their projects in either fundamental or applied research, or a combination of the two approaches.
Scholars Announced
The American Foundation for Urologic Disease recently announced the 2001 participants in the American Foundation for Urologic Disease/ American Urological Association’s Research Scholar Program.
In the M.D. Post-Resident Research Program are: Aristotelis G. Anastasiadis, M.D., Columbia University; Victor M. Brugh, M.D., Baylor College of Medicine; Christopher H. Chay, M.D., University of Michigan; Ithaar H. Derweesh, M.D., Cleveland Clinic Foundation; Ken-ryu Han, M.D., UCLA; Carin V. Hopps, M.D., the Population Council Center for Biomedical Research; Ramsay L. Kuo, M.D., Clarian Health Partners; David I. Lee, M.D., Washington University; Robert Marcovich, M.D., Long Island Jewish Medical Center; Dawn Lee McLellan, M.D., Boston Children’s Hospital; and Giorgi Pirtskhalaishvili, M.D., University of Pittsburgh.
Scholars in the Ph.D. Post-Doctoral Research Program are: Rosalyn M. Adam, Ph.D., Boston Children’s Hospital; and Dumitru Mazilu, Ph.D., Johns Hopkins, Bayview Campus.
Scholars in the M.D./ Ph.D. One Year Research Program are: J. Christopher Austin, M.D., Children’s Hospital of Philadelphia; Carlos E. Bermejo, M.D., University of Texas M. D. Anderson Cancer Center; Roger E. DeFilippo, M.D., Harvard Medical School; and Jyoti Upadhyay, M.D., Hospital for Sick Children, Toronto.
Applications Available
The Cure For Lymphoma Foundation is accepting applications for its new Clinical Investigator Career Development Grant.
The grant will fund training of clinicians to serve as clinical investigators who will participate in developing future diagnostic interventions and treatments for lymphoma.
The grant provides salary and educational support in the amount of $75,000 per year for 3 years. Applicants must provide evidence of adequate research support.
The application deadline is Oct. 12. More information is available at http://www.cfl.org/research.cfm or from Fran Morris, Director of Medical and Scientific Outreach, Cure For Lymphoma Foundation, 215 Lexington Avenue, New York, NY, 10016, 212-213-9595 or 1-800-235-6848, E-mail: fmorris{at}cfl.org.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||